Malignancies associated with systemic lupus erythematosus in Taiwan: A nationwide population-based cohort study

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 773-778

  Liang, Ji An ^a,b   Sun, Li Min ^c   Yeh, Jun Jun ^d   Lin, Wan Yu ^b,e,f   Chang, Shih Ni ^a,g   Sung, Hung Chang ^a,g   Kao, Chia Hung ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Malignancy; Prostate cancer; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; FEMALE; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; COHORT ANALYSIS; COMORBIDITY; FACTUAL DATABASE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; TAIWAN; YOUNG ADULT;

EID: 84860472618     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1684-y     Document Type: Article

References (21)

1. Petri M (2006) Systemic lupus erythematosus and related diseases: clinical features. In: Rose NR, Mackay IR (eds) The autoimmune diseases (forth Edition). Elsevier Academic Press, London, pp 351-356
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265-1270
3. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR (2001) Systemic lupus erythematosus. Lancet 357:1027-1032 (Pubitemid 32285401)
4. Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M, Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 16:309-317 (Pubitemid 47074831)
5. Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52:1481-1490 (Pubitemid 40663940)
6. Bjornadal L, Lofstrom B, Yin L, Lundberg I, Ekbom A (2002) Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31:66-71 (Pubitemid 34518083)
7. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH (1997) Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40:761-768 (Pubitemid 27157584)
8. Kiss E, Kovacs L, Szodoray P (2010) Malignancies in systemic lupus erythematosus. Autoimmun Rev 9:195-199
9. Ragnarsson O, Grondal G, Steinsson K (2003) Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus 12:687-691 (Pubitemid 37173665)
10. Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10:394-400 (Pubitemid 32578613)
11. Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050-1054 (Pubitemid 26182076)
12. Pettersson T, Pukkala E, Teppo L, Friman C (1992) Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51:437-439
13. Lu JF, Hsiao WC (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 22:77-88 (Pubitemid 41388746)
14. Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke AE, Gordon C (2009) Lupus and cancer. Lupus 18:479-485
15. Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497-502
16. Ruiz-Irastorza G, Ugarte A, Egurbide MV, Garmendia M, Pijoan JI, Martinez-Berriotxoa A, Aguirre C (2007) Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Ann Rheum Dis 66:815-817 (Pubitemid 46846704)
17. Cancer incidence and mortality in Taiwan in (2007) Taiwan cancer registry, Department of health, executive Yuan, Taiwan, ROC
18. Sultan SM, Ioannou Y, Isenberg DA (2000) Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology 39:1147-1152
19. Parikh-Patel A, White RH, Allen M, Cress R (2008) Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 19:887-894
20. Nived O, Bengtsson A, Jönsen A, Sturfelt G, Olsson H (2001) Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 10:500-504 (Pubitemid 32675051)
21. Feldman M (1987) Steroid receptor antibodies in autoimmune disorders. Biochem Biophys Res Commun 145:1342-1348